sennoside a&b has been researched along with Cirrhosis, Liver in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, successful therapy for liver fibrosis is still lacking." | 1.62 | Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl ( Ding, Y; Huang, C; Li, J; Ma, T; Xu, S; Zhang, Y; Zhao, H; Zhu, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, H | 2 |
| Zhao, H | 2 |
| Xu, S | 2 |
| Zhang, Y | 1 |
| Ding, Y | 1 |
| Li, J | 2 |
| Huang, C | 2 |
| Ma, T | 2 |
| He, C | 1 |
| Jiang, W | 1 |
2 other studies available for sennoside a&b and Cirrhosis, Liver
| Article | Year |
|---|---|
Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl
Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemical and | 2021 |
Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation.
Topics: Actins; Animals; Cell Line; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyc | 2020 |